Lineagen CEO and leadership

Purpose-driven company and team builder with more than 25 years of life science industry experience including 15+ years as CEO, leading organizations from formation to strategic exit. Proven experience in raising equity and debt capital, and developing strategic plans that result in demonstrable commercial value. Strong track record of negotiating and managing corporate and academic partnerships that drive value-creation, developing effective and aligned executive and operational teams, and recruiting highly-experienced Board of Directors. • “Start to Finish” CEO with experience in all company phases from seed stage to multi-million revenue product commercialization to strategic exit.Responsibility-centered leader who builds cohesive and intellectually aligned executive teams held accountable for collective results. • Proven success in raising multiple rounds of equity and debt capital from venture capital investors, banks, and corporate partners. • Extremely effective in communicating, both internally and externally, the “why” behind an organization’s existence and basis for its success. • Source, negotiate, close, and manage value-creating partnerships with “brand name” academic, pharmaceutical, biotech, and technology companies. • Strong educational foundation and hands-on experience in developing and implementing strategic plans that create value in early and mid-stage stage organizations. • Reputation among board members and employees as a dedicated and inspirational leader with the ability to motivate and maintain teams throughout a company’s lifecycle.• Experience in developing and executing on business models in both rare disease diagnostics and rare disease therapeutics.

Purpose-driven company and team builder with more than 25 years of life science industry experience including 15+ years as CEO, leading organizations from formation to strategic exit. Proven experience in raising equity and debt capital, and developing strategic plans that result in demonstrable commercial value. Strong track record of negotiating and managing corporate and academic partnerships that drive value-creation, developing effective and aligned executive and operational teams, and recruiting highly-experienced Board of Directors. • “Start to Finish” CEO with experience in all company phases from seed stage to multi-million revenue product commercialization to strategic exit.Responsibility-centered leader who builds cohesive and intellectually aligned executive teams held accountable for collective results. • Proven success in raising multiple rounds of equity and debt capital from venture capital investors, banks, and corporate partners. • Extremely effective in communicating, both internally and externally, the “why” behind an organization’s existence and basis for its success. • Source, negotiate, close, and manage value-creating partnerships with “brand name” academic, pharmaceutical, biotech, and technology companies. • Strong educational foundation and hands-on experience in developing and implementing strategic plans that create value in early and mid-stage stage organizations. • Reputation among board members and employees as a dedicated and inspirational leader with the ability to motivate and maintain teams throughout a company’s lifecycle.• Experience in developing and executing on business models in both rare disease diagnostics and rare disease therapeutics.